Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
5-HT2 RECEPTORS FACILITATE JC POLYOMAVIRUS ENTRY.
Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis?
Syringomyelia coexisting with guillain-barre syndrome.
Neuromyelitis optica in child: diagnostic and therapeutic challenges.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
Editorial comment.
The effects of exercise training on fitness, mobility, fatigue, and health related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development.
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Role of TNF in mast cell neuroinflammation and pain.
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis.

Pages